RTX-CDC varies as a function of patient sera and correlates with RF levels. A. RTX-CDC using Daudi cell line with 1% human sera stratified by disease state: healthy donors, non-RA disease, seronegative RA (RF-), and seropositive RA (RF+). Data represent the mean cell death obtained with 15 sera in each category except for RF+ (n = 40). B, C, D. RTX-CDC cell death declines with increasing titer of RF, with a stronger correlation with IgM RF. Error bars represent mean standard error.
Jones et al. Arthritis Research & Therapy 2013 15:R20 doi:10.1186/ar4152